- Home
- YETI vs ELVN Comparison
YETI vs ELVN Comparison
Compare YETI & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YETI | ELVN |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.2B |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | YETI | ELVN |
|---|---|---|
| Price | $41.78 | $61.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $47.75 | $43.40 |
| AVG Volume (30 Days) | ★ 1.8M | 1.0M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.17 |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $1,868,494,000.00 | N/A |
| Revenue This Year | $9.07 | N/A |
| Revenue Next Year | $7.11 | N/A |
| P/E Ratio | $39.42 | ★ N/A |
| Revenue Growth | ★ 2.11 | N/A |
| 52 Week Low | $31.66 | $14.79 |
| 52 Week High | $53.99 | $62.32 |
Technical Indicators
Market Signals| Indicator | YETI | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 29.19 | 64.85 |
| Support Level | $38.06 | $56.69 |
| Resistance Level | $42.68 | $62.32 |
| Average True Range (ATR) | 1.72 | 1.89 |
| MACD | -0.64 | -0.18 |
| Stochastic Oscillator | 0.00 | 77.21 |
Price Performance
Historical ComparisonAbout YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.